SAFE study (Safety and efficacy Analysis of FRED Embolic device in aneurysm treatment): 1-year clinical and anatomical results

Abstract : Flow diversion is an innovative and increasingly used endovascular treatment for intracranial aneurysms. Its initial evaluation with the first devices available showed good efficacy of this treatment with variable safety results. The Flow Direction Endoluminal Device (FRED) has a specific design and was evaluated in a single-arm, multicenter, prospective, Good Clinical Practice study: SAFE (Safety and efficacy Analysis of FRED Embolic device in aneurysm treatment). This analysis reports clinical results at 1 year and anatomical results at 6 months and 1 year.
Keywords : aneurysm flow diverter
Document type :
Journal articles
Complete list of metadatas

https://www.hal.inserm.fr/inserm-01936823
Contributor : Jean-Yves Gauvrit <>
Submitted on : Tuesday, November 27, 2018 - 4:22:05 PM
Last modification on : Wednesday, December 11, 2019 - 3:22:08 PM

Links full text

Identifiers

Collections

Citation

Laurent Pierot, Laurent Spelle, Jérôme Berge, Anne-Christine Januel, Denis Herbreteau, et al.. SAFE study (Safety and efficacy Analysis of FRED Embolic device in aneurysm treatment): 1-year clinical and anatomical results. Journal of Neurointerventional Surgery, BMJ Journals, 2018, ⟨10.1136/neurintsurg-2018-014261⟩. ⟨inserm-01936823⟩

Share

Metrics

Record views

54